Mark Scott
Technik-/Wissenschafts-/F&E-Leiter bei Next Level Health Sciences, Inc.
Profil
Mark Scott currently works as a Director & Chief Technology Officer at Next Level Health Sciences, Inc.
Aktive Positionen von Mark Scott
Unternehmen | Position | Beginn |
---|---|---|
Next Level Health Sciences, Inc.
Next Level Health Sciences, Inc. Information Technology ServicesTechnology Services The Canadian company creates novel formulations that promote a healthier relationship between consumers and adult use recreational substances. The private company also develops licensable technologies that improve the delivery of biopsychoactives™ and reduce the reliance and dependency on addictive substances by preventing much of the damage these substances cause in the body. The company's first product, Hangovr-18o™, prevents hangovers using plant-based ingredients to support enzyme production in the liver, naturally sourced humic-fulvic acid to hydrate and detoxify, and S-acetyl glutathione to prevent oxidative cellular damage. The integration of their expertise in biopsychoactives™ delivery technologies, their understanding of functional medicine, and their science-backed, evidence-based approach to novel fortified food and nutraceutical formulations uniquely positions them within the adult recreational intoxicants market. Next Level Health Sciences, Inc. is a Vancouver-based company founded by David Weinkauf, who has been the CEO since incorporation. | Technik-/Wissenschafts-/F&E-Leiter | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Next Level Health Sciences, Inc.
Next Level Health Sciences, Inc. Information Technology ServicesTechnology Services The Canadian company creates novel formulations that promote a healthier relationship between consumers and adult use recreational substances. The private company also develops licensable technologies that improve the delivery of biopsychoactives™ and reduce the reliance and dependency on addictive substances by preventing much of the damage these substances cause in the body. The company's first product, Hangovr-18o™, prevents hangovers using plant-based ingredients to support enzyme production in the liver, naturally sourced humic-fulvic acid to hydrate and detoxify, and S-acetyl glutathione to prevent oxidative cellular damage. The integration of their expertise in biopsychoactives™ delivery technologies, their understanding of functional medicine, and their science-backed, evidence-based approach to novel fortified food and nutraceutical formulations uniquely positions them within the adult recreational intoxicants market. Next Level Health Sciences, Inc. is a Vancouver-based company founded by David Weinkauf, who has been the CEO since incorporation. | Technology Services |